Pharmaceutical manufacturers should stop being overly cautious about the risks of closed systems and consider the benefits they could bring to patient care, according to David Estapé of CRB Group. He argues that companies can often overstate the risks posed by minuscule factors, disregarding the benefits closed systems could bring to delivery. Regulators also hamper progress by prolonging approval processes, Estapé added.
7 Malicious Go Packages Target Linux & macOS to Deploy Stealthy Malware Loader
Socket security researchers have discovered a sophisticated malware campaign targeting the Go ecosystem. The unknown attacker, using malware hidden inside seven fake Go packages on
